The Infectious Disease Research Center (IDRC) at Colorado State University is a dynamic, rapidly growing complex of buildings designed and operated at a truly state-of-the-art level. The focus of these facilities is on infectious disease research designated as BSL-3, the next-to-the-highest classification of agents based on risk. The Center consists of five inter-connected buildings of BSL-2 and BSL-3 space, and cost nearly $50,000,000 to construct with total space capacity of the Center of over 100,000 square feet.
Special features of the Center are a GMP Manufacturing Laboratory with BSL2 and BL3 capability, an Animal Models Core, Arbovirology unit, the Rocky Mountain Regional Biocontainment Laboratory, and the Research Innovation Center that houses a Biotech incubator fostering startup companies to conduct life science R&D. Most of the laboratories in the Center are certified by the Centers for Disease Control and U.S. Department of Agriculture for work with bacterial and viral select agents; As a former Rocky Mountain Center of Excellence, the Center’s mission is to perform basic research on emerging infectious diseases and potential biothreat agents and engage in the development of better vaccines, diagnostics and therapeutics for these diseases and agents. The unique capabilities of the IDRC provide an opportunity for academic, government, and private sector researchers to collaborate and engage in cutting-edge infectious disease research..
You are encouraged to use this web site to explore our programs and people, and please do not hesitate to call, write, or e-mail us.